v3.26.1
REVENUES AND ENTITY WIDE DISCLOSURES (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Dec. 31, 2023
Disaggregation of Revenue [Line Items]          
Contract fulfilment asset   $ 1,017   $ 1,256
Contract liability   165 2,075   $ 2,322
Accounts receivable   278 1,510    
REVENUES   3,015 3,964    
Revenue, Remaining Performance Obligation, Amount   13,800      
Long-Term Purchase Commitment, Amount $ 10,000        
Development and Manufacturing Services [Member]          
Disaggregation of Revenue [Line Items]          
REVENUES   $ 1,150      
Fortune 500 Medical Company Customer [Member]          
Disaggregation of Revenue [Line Items]          
Accounts receivable     $ 847    
Related Development Costs [Member]          
Disaggregation of Revenue [Line Items]          
Contract fulfilment asset       $ 957  
Contract liability       $ 1,690